The contraceptive patch. Latest developments.
Courtney
Kathleen
K
Frances Payne Bolton School of Nursing, Case Western Reserve University, Cleveland, OH, USA.
D000279:Administration, Cutaneous; D003277:Contraceptives, Oral, Combined / Q000008:administration & dosage* / Q000009:adverse effects; D004338:Drug Combinations; D004346:Drug Information Services; D016903:Drug Monitoring; D004967:Estrogens / Q000097:blood; D004997:Ethinyl Estradiol / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D009644:Norgestrel / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D024802:Nurse's Role; D009730:Nursing Assessment; D018570:Risk Assessment; D012307:Risk Factors; D012449:Safety; D012869:Skin Absorption; D014481:United States; D014486:United States Food and Drug Administration
D003277:Contraceptives, Oral, Combined; D004338:Drug Combinations; D004967:Estrogens; C511292:Ortho Evra; D009644:Norgestrel; D004997:Ethinyl Estradiol